Fiche détaillée de la technologie
Titre de la technologie / Technology Title
S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
The present invention relates to a method and composition for inducing leukocyte proliferation and migration, and for reducing the risks of microbial infections in patients immuno-suppressed. The present invention particularly relates to ,MRP which induces the proliferation, differentiation and release of immune cells from bone marrow. More particularly, S100A8, S100A9, S100A12 and S100A8/A9 are administered to patients with lowered neutrophil blood concentrations.
- Karen Vandal
- Pascal Rouleau
- Carle Ryckman